Design and synthesis of potent and selective macrocyclic thrombin inhibitors
Nantermet, P.G., Barrow, J.C., Newton, C.L., Pellicore, J.M., Young, M., Lewis, S.D., Lucas, B.J., Krueger, J.A., McMasters, D.R., Yan, Y., Kuo, L.C., Vacca, J.P., Selnick, H.G.(2003) Bioorg Med Chem Lett 13: 2781-2784
- PubMed: 12873514 
- DOI: https://doi.org/10.1016/s0960-894x(03)00506-7
- Primary Citation of Related Structures:  
1NM6, 1NT1 - PubMed Abstract: 
A series of potent and selective proline- and pyrazinone-based macrocyclic thrombin inhibitors is described. Detailed SAR studies led to the incorporation of specific functional groups in the tether that enhanced functional activity against thrombin and provided exquisite selectivity against trypsin and tPA. X-ray crystallography and molecular modeling studies revealed the inhibitor-enzyme interactions responsible for this selectivity.
Organizational Affiliation: 
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. philippe_nanternet@merck.com